We have cloned and characterized a novel human serine/ threonine protein kinase gene from chromosome 12p13.3 encoding 2382 amino acids. Remarkably, the catalytic domain sequence contains a cysteine in place of a lysine residue conserved in subdomain II of most kinases. The same amino acid alteration was recently described for rat WNK1 (with no K=lysine) in which another nearby lysine residue was shown to confer kinase activity to the protein. Rat WNK1 is 85% identical to a splice variant lacking exons 11 and 12 of the described human kinase which we have called human WNK1. The WNK1 catalytic domain has closest homology with human PAK2, MEKK3, and Raf-1. Three additional, partial human protein kinase sequences, WNK2, WNK3 and WNK4, are also reported here with catalytic domains that are 95% homologous to WNK1. These genes dier both in chromosomal location and tissue-speci®c expression. Moreover, we have identi®ed in the database a total of 18 WNK-related genes, all exclusively from multicellular organisms, which share a WNK kinase sequence signature within subdomains I and II of the catalytic domain. We suggest that they constitute a novel subfamily of protein kinases that evolved together with cell adhesion and tissue-formation. Oncogene (2001) 20, 5562 ± 5569.
Introduction
Protein kinases form a superfamily of enzymes that act as important mediators in the regulation of many cellular processes (Hunter, 2000) . They become activated by upstream signals and positively or negatively regulate the activity of downstream protein substrates via phosphorylation. Protein kinases often provide`molecular switches' that rapidly and reversibly respond to speci®c signals and can integrate multiple signalling pathways in many dierent cellular responses such as cell growth, death, division, transformation, movement, embryonic development and regeneration (Dhanasekaran, 1998) . For instance, activation of both growth factor receptors and integrin-mediated cell adhesion are required to stimulate the mitogenactivated protein kinase (MAPK) cascades, organise the cytoskeleton, and protect cells from apoptosis (Kumar, 1998) .
The MAP kinase cascades (reviewed by Denhardt, 1996; Dhanasekaran and Reddy, 1998; Garrington and Johnson, 1999; Chang and Karin, 2001 ) transduce extracellular signals from the plasma membrane to the nucleus through activation of transcription factors that elicit changes in gene expression and thus in cell metabolism. The original MAPK pathway is activated by growth factor receptors and involves the small GTPase Ras. Activated Ras GTP binds to and activates the MAP kinase kinase kinase (MAP3K) Raf, thus initiating the Raf-MEK-ERK cascade. At least three other kinase cascade pathways have now been identi®ed involving the stress-activated protein kinases (SAPK/JNK), p38-MAPK and ERK5. These pathways include activation of Rac or Cdc42 GTPases which activate MAP4Ks such as PAK which in turn stimulate speci®c MEKKs, MKKs and then JNK, p38 MAPK or ERK5.
More and more protein kinases have been described in the last decades and from the sequence of the human genome a number of over 1000 is now estimated to exist (Hunter, 2000) , as was predicted almost 15 years ago (Hunter, 1987) . This number re¯ects the current notion that signal transduction pathways are not linear cascades of events but rather complex networks and circuits of positive and negative feedback loops.
From the structural point of view protein kinases are an extremely heterogeneous family of proteins with high homology over their catalytic domains. The catalytic domain is subdivided into 12 subdomains comprising 250 ± 300 amino acids. Some of these residues are invariant and play a crucial role in maintaining the two-lobed folding of the catalytic domain, or in providing enzymatic activity (Hanks and Hunter, 1995) . For example, subdomain I consists of two b-strand structures that are separated by a loop containing invariant glycine residues. This glycine string acts like a¯exible¯ap covering and anchoring the non-transferable phosphate groups of ATP (Bossemeyer, 1994) . Another example is a conserved lysine residue in subdomain II of the catalytic core (corresponding to Lys72 of protein kinase A) that anchors and orientates the a and b phosphoryl groups of ATP (Knighton et al., 1991; Bossemeyer et al., 1993) . In vitro mutagenesis of this residue, or the catalytic aspartate in subdomain VIb, have been used in many kinases to study the eect of kinase-dead mutants.
Here we describe a novel protein kinase that has an unexpected amino acid sequence variation in subdomains I and II when compared to the conserved catalytic domain of other kinases. We report the ®rst human kinase among a number of related genes from various species and propose that they constitute a novel protein kinase subfamily.
Results

Identification of a novel human protein kinase sequence
When the expression of protein kinases was studied by the Dierential Display technique (Liang et al., 1993) in invasive colorectal cell lines a transcript for a novel serine/threonine kinase was identi®ed (unpublished data). Database comparison of this partial kinase clone revealed a related genomic kinase sequence from BAC clone RP11-388A16 on chromosome 12 (GenBank accession number AC004765). In order to predict the corresponding coding sequence the genomic raw data was analysed with the Genscan software which revealed many potential exons and extension of an open reading frame into the overlapping BAC clone RP11-359B12 (GenBank accession number AC004803). Gene prediction alone cannot currently identify exons in a reliable manner (see Jordan et al., 2000 and references therein) . Typical prediction errors are that (i) intronic sequences are over-predicted as additional exons; (ii) small or alternatively spliced exons with weaker splice site consensus values are missed; and (iii) the exact position of one splice junction can be shifted some nucleotides away, especially frequent in the ®rst coding exon. To overcome these problems the putative ®rst and last exon were checked for matching clones in the EST-database and primers were designed to amplify by RT ± PCR the coding sequence, as expressed in vivo. The corresponding cDNA product was then subcloned and sequenced. This approach allowed us to determine the complete coding sequence and to deduce the correct genomic structure of the gene.
Analysis of the WNK1 coding sequence
The complete coding sequence of the novel gene encompasses 7149 bp or 2382 amino acids and codes for a protein of 251 kDa (GenBank accession number AJ296290). Analysis of the coding sequence is shown in Figure 1a and reveals a protein kinase catalytic domain between residues 221 and 479. The motifs IIHRDLKCDNIFI' in subdomain VIb and`GTPEF-MAPE' in subdomain VIII further suggest that this protein is a serine/threonine kinase (Taylor et al., 1995) . In addition, the predicted amino acid sequence contains three potential coiled-coil and four prolinerich regions. A glutamine-rich region (residues 571 ± 812), two serine-rich regions (residues 1404 ± 1562, 2027 ± 2065) and a total of 33 PXXP motifs recognized by SH3 domains are present, as well as a potential bipartite nuclear localization signal located between residues 567 and 584 that overlaps the second coiledcoil region.
Human kinases with closest homology to the catalytic domain of this novel protein are the serine/ threonine-protein kinases STK2, PAK2, MEKK3, PAK3 and Raf-1 (approximately 30% sequence identity and 50% sequence homology). These homologies suggest that the novel kinase is a member of the mitogen-activated protein kinases.
A most remarkable feature of the novel kinase sequence is the replacement of the conserved lysine residue in subdomain II of the catalytic domain by a cysteine (Figure 1b ). This speci®c lysine residue is involved in ATP binding in almost all kinases reported to date and has been frequently used to generate dominant negative protein kinase mutants. Interestingly, a new rat protein kinase called WNK1 (with no K (=lysine)) was recently shown to contain the same lysine-to-cysteine alteration, and the authors demonstrated that another nearby lysine residue, located within the glycine string of subdomain I, confers kinase activity (Xu et al., 2000; Figure 1b ). The human kinase described here is 85.6% identical to rat WNK1 and thus corresponds to human WNK1.
During RT ± PCR ampli®cation of full-length WNK1 from human heart or colon cDNA, further products were isolated that correspond to WNK1 splice variants lacking either exon 12, or exons 11 and 12, or exons 9, 11 and 12. The ratio of expression of the full length versus the alternatively spliced variants remains to be determined. Interestingly, the recently described rat WNK1 corresponds to the human splice The distinct catalytically active lysine that acts in rat WNK1 Ser/ Thr-kinase (Xu et al., 2000) is marked and is conserved in human WNK1
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Analysis of the genomic sequence
The gene for the human protein kinase WNK1, ocial gene symbol PRKWNK1, spans 160 kb of genomic DNA (see Figure 2a) and contains 28 exons which all follow the classical AG-GT rule at their exon-intron borders (see Figure 2b) . We con®rmed by FISH that the corresponding genomic clone, RP11-388A16, maps to chromosome 12p13.3 (data not shown) and identi®ed a variety of STS markers such as D12S94, D12S91, D12S1397, G41230 and G41789 within the gene. This information allows us to localize PRKWNK1 between the cell adhesion gene ninjurin2 (telomeric) and the DNA repair gene RAD52 (centromeric) (see map at www.hgsc.bcm.tmc.edu/seq_data/ maps/human/12p13.3-0.2.7.html).
Exon 1 encodes the N-terminal 253 amino acids including subdomains I and II of the catalytic protein kinase domain. This is interesting from the evolutionary point of view since these two subdomains dier from other protein kinases, as described above. Exon 1 is surrounded by a large CpG-island that extends from nt 1453 upstream of the translation start codon ATG until nt 166 of intron 1. Comparison of the sequence with the human EST database revealed at least four potential transcription initiation sites at nucleotides 7206 (GenBank accession number AI678098), nt 7251 (GenBank accession numbers AI678098, AI739293, AI380862), nt 7404 (GenBank accession number AI932347) and nt 7644 (GenBank accession number AF061944; Moore et al., 2000) . The upstream, putative promoter region is GC-rich with no TATAbox preceding any of the putative transcription start sites.
The 3' untranslated region (UTR) was analysed by comparison to the EST database as described previously (Jordan et al., 2000) . The UTR is continuous with no further exons and two consensus polyadenylation sites, aataaa, which match the end of various ESTs. The ®rst polyA signal is located between nt 823 and 829 (e.g. GenBank accession numbers AI085385, AA830670) downstream of the translation stop codon and the transcript cleaved at nucleotide 846, or 848. The second polyA site is found at 2636 to 2641 bp (e.g. GenBank accession numbers AI346862, AI342236) with cleavage site at 2659 bp downstream of the translation stop codon. 
Expression of WNK1
Considering the coding sequence of 7149 bp, preceded by various upstream transcription initiation sites between 206 and 644 bp, the size of the two transcripts generated at both polyadenylation sites would be predicted to vary between 8203 ± 8641 bp and 10014 ± 10452 bp, respectively (ignoring smaller transcripts that might originate from alternative splicing). Detection of the human WNK1 transcript by Northern blotting is shown in Figure 3a and revealed two transcripts of approximately 8.5 kb and 10 kb. This is in good agreement with the values deduced from the genomic PRKWNK1 sequence. Both WNK 1 transcripts are expressed in most human tissues analysed, most strongly in heart and muscle ( Figure 3a) . To address whether variations in WNK1 mRNA expression corresponded to WNK1 protein levels, total lysates of selected tissues were analysed by Western Blot using a WNK1 antipeptide antibody (Xu et al., 2000) . In human heart showing strong mRNA levels two clear protein bands of 4250 kDa were observed whereas only one weak band was detected in brain or kidney (Figure 3b ). In addition, cell lysates from a breast (ZR75.1) and colon (SW480) cell lines that were positive for WNK1 expression by RT ± PCR contained one major protein band. Liver and small intestine as weak expressing tissues showed no detectable protein levels. Thus, the protein levels roughly match mRNA levels, and the second band present in heart could indicate alternatively spliced WNK1 protein.
At least three additional human WNK1-related protein kinases exist
Database searches revealed the existence of additional human kinase sequences with high homology to WNK1: two partial genomic sequences, one from chromosome X (GenBank accession number AL049793) and one from chromosome 17 (GenBank accession number AC016889), as well as a cDNA fragment described by us and others (GenBank accession number AJ242724 and AB044546). We have predicted the catalytic domain sequence for these three genes and ampli®ed them by RT ± PCR. A sequence alignment of the catalytic domains of all four genes is given in Figure 5a and revealed the typical alterations in subdomain I and II, i.e. cysteine in position of the classical conserved catalytic lysine residue, and the alternative catalytic lysine, identi®ed by Xu et al. (2000) that is located within the glycine string. Sequence identities with respect to the human WNK1 catalytic domain are 91, 93 and 83% for the genes from chromosomes 9, X and 17, respectively. Although the complete sequences of three of the four genes remain to be determined, it appears that sequence similarity outside the catalytic domain is signi®cantly lower.
To get further evidence that these four sequences represented distinct genes we localised by FISH the gene corresponding to the cDNA fragment described above. Primers were designed in two adjacent exons and a corresponding intron of 7.5 kb was ampli®ed by PCR from genomic DNA. This probe speci®cally labelled chromosome 9q22.3 (Figure 4 ). The dierent chromosomal locations and the sequence homologies strongly suggest that the four genes are members of the same kinase subfamily. We therefore propose to name these novel human kinases WNK1 (chromosome 12p13.3), WNK2 (chromosome 9q22.3), WNK3 (chromosome Xp11.21-23) and WNK4 (chromosome 17q) (ocial HUGO nomenclature PRKWNK1-PRKWNK4).
To determine whether the four human WNK kinases are expressed in dierent tissues, speci®c RT ± PCR conditions were developed for each novel protein kinase transcript and the PCR products sequenced to con®rm identity with the four WNK genes. Subsequently, a series of RNAs from human adult as well as foetal tissues were analysed and distinct expression pro®les observed for the four genes, as shown in Figure 5b . WNK1 is expressed in most tissues examined, WNK2 is predominantly expressed in heart, brain and colon, WNK3 is mostly expressed in brain and WNK4 expression was found in colon and skin. These data indicate tissue-speci®c functions for each WNK kinase, both during 
Migration of molecular weight markers is indicated
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The WNK-kinases form a novel subfamily of protein kinases
A database search with the sequence motif from subdomain I and II that characterizes the human and rat WNK kinases revealed various homologous kinase genes in other species: one homologue in Drosophila melanogaster, one in Caenorhabditis elegans, one in the plant Fagus sylvatica, two in Oryza sativa and eight in Arabidopsis thaliana, but none in yeast. The corresponding alignment is shown in Figure 6 . Eleven out of 33 residues were found to be invariant in subdomains I and II of all 18 WNKrelated kinases, including the key catalytic lysine residue described for rat WNK1 (Xu et al., 2000) . This allows the identi®cation of a WNK-kinase signature sequence that will be useful to identify further human family members as sequencing and annotation of the human genome progresses, or to designate the corresponding homologues from other species, such as mouse.
a Figure 5 (a) Alignment of the catalytic domains of the four human WNK-kinases. The 11 subdomains are separated by bars and labelled using roman numerals above the WNK1 sequence. The position of exon junctions are identical in all four genes, as indicated by arrowheads. Box-shaded residues dier from the WNK1 sequence, and bold-underlined amino acids in WNK1 are the invariant kinase residues described by Hanks and Hunter (1995) . Accession numbers from top to bottom are AJ296290; AB044546; AJ409088; AC016889+AJ309861. (b) RT ± PCR analysis of expression of WNK1, WNK2, WNK3 and WNK4 kinases in a panel of foetal (f.) and adult human tissues. Bar indicates position of the 600 bp marker. Note the dierent expression pro®les Figure 4 Chromosomal localization of the PRKWNK2 gene. Fluorescence in situ hybridization detected the gene for kinase WNK2 at chromosome 9q22.3 (see arrowheads and drawing) using routine cytogenetic procedures. A 7.5 kb WNK2 intron was ampli®ed by PCR and subcloned, then digoxigenin-labelled, hybridized to metaphase spreads from normal peripheral blood lymphocytes, and stained with anti-digoxigenin conjugated to rhodamine WNK1, a novel human protein kinase F Verõ Âssimo and P Jordan
Discussion
We have described the coding sequence and genomic structure of a novel human protein kinase, WNK1. Protein kinases represent a superfamily with currently over 400 members in 57 subfamilies that share a similar kinase catalytic domain of 250 ± 300 amino acids in which various sequence motifs are highly conserved. The WNK1 catalytic domain contains all invariant residues depicted by Hanks and Hunter (1995) (see Figure 5a ), except for the lysine residue in subdomain II. This is a very speci®c characteristic of WNK1 given that all 390 eucaryotic and prokaryotic protein kinases aligned at the Protein Kinase Resource website (www.sdsc.edu/kinases/pk_home.html) share that conserved lysine in subdomain II. As was shown by Xu et al. (2000) another nearby lysine, localized in the glycine string of subdomain I, functionally substitutes for it and is required for catalytic activity. The WNK1-speci®c catalytic lysine residue in subdomain I is found in three further, partial human protein kinase sequences and their catalytic domains are 95% homologous to WNK1 (see Figure 5a) . These kinases dier, however, both in tissue-speci®c expression and in chromosomal location of their corresponding genes. The kinases were designated WNK2, WNK3 and WNK4. It cannot be excluded that further human WNK-related genes will be uncovered as sequencing and annotation of the human genome progress. Various WNK genes also seem to appear in rodents since a second WNK1-related clone was identi®ed from rat (Xu et al., 2000) . In addition, we were able to amplify by lowstringency PCR a portion of mouse WNK2 (data not shown). Furthermore, a variety of WNK-related gene sequences were isolated from invertebrates and plants (see Figure 6 ). We therefore propose that they are all members of a new subgroup within the protein kinase superfamily (Hanks and Hunter, 1995) . The alignment of 18 WNK-related genes from various organisms allowed identi®cation of a respective sequence signature within subdomains I and II of the WNK catalytic domain.
The existence of various WNK-related kinase genes gains further complexity through the alternative splicing observed. At least three human variants concerning exons 9 or 11 or 12 were isolated and rat WNK1, for which kinase activity was demonstrated (Xu et al., 2000) , corresponds to one of them. The determination of the human PRKWNK1 gene structure, spanning 160 kb and containing 28 exons, allowed us to distinguish between these WNK1 variants and the WNK2, WNK3 and WNK4 genes.
It is interesting to note that in the completely sequenced genomes from the nematode C. elegans and the¯y D. melanogaster only one WNK-like kinase sequence was detected, whereas the yeast or bacterial genomes contain no WNK-homologous gene. This indicates that WNK protein kinases are speci®c for multi-cellular organisms and that the number of WNK genes re¯ects an organism's complexity. A major step from a unicellular to a multi-cellular organism is the establishment of a complex cell-tocell and cell-to-matrix adhesion system. We therefore propose that WNK kinases play a role in signalling related to cell adhesion, and possibly transformation, a hypothesis to be tested in the future. Compatible with this idea is the close sequence homology to human protein kinases at the MAP kinase kinase kinase level, such as PAK, MEKK3 and Raf. The identi®cation of proline-rich regions and potential Figure 6 The sequence signature of the WNK-family of protein kinases. Alignment of subdomains I and II of the catalytic domains from 18 WNK-like kinase genes from various species. The sequence signature of invariant residues in all members is given below the alignment. Species abbreviations: are hs, Homo sapiens; rn, Rattus norvegicus; ce, Caenorhabditis elegans; dm, Drosophila melanogaster; at, Arabidopsis thaliana; os, Oryza sativa; fs, Fagus sylvatica;`+'=K or R;`a'=aromatic (F or Y) Oncogene WNK1, a novel human protein kinase F Verõ Âssimo and P Jordan coiled-coil regions does further indicate multiple interactions with other proteins. Apart from the catalytic domain the coding sequence of WNK1 does, however, not resemble any other protein in the database.
Taken together, our data describe the novel human protein kinase WNK1 and reveal a novel subfamily of protein kinases with a structural variation in subdomains I and II of the catalytic domain. We have shown that in man there are at least four members of this family and de®ne a WNK kinase sequence signature by comparing 18 related genes from dierent species, all exclusively multi-cellular organisms.
Materials and methods
RT ± PCR, cloning and sequencing of WNK1 cDNA
Total RNA was isolated from the T47D breast carcinoma cell line (RNeasy-kit, Qiagen) and reverse transcribed. WNK1 cDNA was ampli®ed as two overlapping fragments from both T47D cDNA or human heart Marathon cDNA (Clontech) using rTthXL polymerase (Perkin Elmer) according to the manufacturer's instructions. Fragment 1 (nt 1 ± 1615) was ampli®ed using primers PK12-5-FL2 (5'-TCTGGCGGCGCCGCAGAGAA-3') and PK12-R2 (5'-CTTGTGCAACATCTTCTGGGACA-3') in 37 cycles of 938C-60 s, 628C-30 s, 688C-2 min with an initial denaturation of 2 min at 938C and a ®nal extension of 15 min at 728C. Fragment 2 (nt 654 ± 7149) was ampli®ed as above but primers PK12-F1 (5'-CCGCTTTCTCAAGTTTGACATC-GA-3') and PK12-3-FL2 (5'-GTCTAAGTGGTCCGCA-GGTT-3') and an extension of 8 min at 688C in each cycle. Products were subcloned using the Topo-XL-cloning kit (Invitrogen), positive colonies sequenced with the BigDyeterminator cycle sequencing kit (Perkin Elmer) and analysed on the ABI Prism 377 automated DNA sequencer.
Expression studies of WNK1-WNK4 by RT ± PCR
The expression pro®le of the four human WNK kinases was studied by RT ± PCR in various human adult and foetal tissues. Total tissue RNA (kind gift of E Chastre, Paris) was reverse transcribed using oligo-dT primers and then ampli®ed with either primers PK12-F1 (5'-CCGCTTTCTCAAGTTTG-ACATCGA-3') and PK12-R1 (5'-CCGCTTCAGGGTTGC-CAGACCG) (WNK1), primers PK6-8 (5'-CTTCTGGACCG-GAAGCTCA) and PK6-10R (5'-GATGGACTTGGCCACG-ATCTT) (WNK2), or primers PK6X-F (5'-GATTCCTGG-GAATCTATATT) and PK6X-R (5'-GGTACGCATTAAG-GTGGCTAAT) (WNK3), or primers PK17-F1 (5'-GTCGG-TGCTGAGGGGCCAGGTTT) and PK17-R2 (5'-GTTCGG-CTTTCTGCCCGAA) (WNK4) using AmpliTaq polymerase (Perkin Elmer) in 30 cycles of 948C-30 s, 608C or 588C or 548C or 588C, respectively-45 s, 728C-1 min with an initial denaturation of 2 min at 948C and a ®nal extension of 5 min at 728C. In order to con®rm that each primer pair was gene-speci®c, representative RT ± PCR products were subcloned using the Topo-TA-cloning kit (Invitrogen) and ®ve positive colonies sequenced (BigDye-terminator kit and ABI Prism 377, Perkin Elmer). No ampli®cation was obtained when RNA was mock reverse transcribed without adding reverse transcriptase, demonstrating that ampli®cation was not due to contaminating genomic DNA.
Protein sequence analysis
Sequence homologies were determined via the BLAST software at http://www.ncbi.nlm.nih.gov/blast/blast.cgi?Jform=1 and multiple sequence alignments generated with the ClustalW1.8 software at http://dot.imgen.bcm.tmc.edu:9331/multi-align.html. Protein motifs were searched against the Pro®leScan library at http://www.isrec.isb-sib.ch/ software/PFSCAN_form.html and coiled-coil structures predicted with the COILS algorithm at http://www.ch.embnet.org/software/COILS_form.html.
Fluorescence in situ hybridization
Probes for¯uorescence in situ hybridization (FISH) were either BAC clone RP11-388A16 (WNK1) or a 7.5 kb intron of WNK2 ampli®ed from genomic DNA by rTth polymerase (Perkin Elmer) according to the manufacturer's instructions using exonic primers PK6-12F (5'-GACCACGGCAG-GAAGTCCA) and PK6-10R (5'-GATGGACTTGGCCAC-GATCTT) (GenBank accession number AL390760.4, nts 68979 ± 76544).
Metaphase spreads were prepared from peripheral blood lymphocytes of healthy individuals according to standard cytogenetic techniques. Slides were pretreated with 0.1 mg/ml pepsin at pH 2, then ®xed in 1% formaldehyde-phosphate buered saline before dehydration through an ethanol series. Probes were digoxigenin-labelled using a nick-translation kit (Gibco-BRL), denatured simultaneously with chromosomal DNA at 808C for 5 min in hybridization buer (50% formamide, 26SSC, 50 mM phosphate buer, pH 7, 10% dextran sulphate) and then hybridized for 16 h at 408C in a humid chamber. Post-hybridization washes were 365 min in 0.056SSC followed by 5 min in 0.15 M NaHCO 3 containing 0.1% Tween 20 and 0.45% BSA, all at 408C. The digoxigenin-labelled probe was stained with anti-digoxigenin-Fab fragments conjugated to rhodamine (Roche), washed 365 min in 0.15 M NaHCO 3 containing 0.1% Tween 20, the slides then mounted in Vectashield (Vector Lab.) and analysed on a Zeiss axiophot¯uorescence microscope with a cooled CCD camera controlled by the MacProbe software (PSI).
Northern blot analysis
A human multiple tissue Northern blot was purchased from Clontech, hybridized with a radio-labelled (Multiprime labelling kit, Amersham Pharmacia) WNK1 cDNA probe comprising nucleotides 1226 ± 1937 (Acc. no. AJ296290) and washed according to the manufacturer's instructions. As loading and RNA quality control the blot was rehybridized with a b-actin probe supplied by the manufacturer.
Western blot analysis
Whole tissue protein extracts were purchased from Clontech and cultured cells lysed directly in SDS-sample buer. Proteins (100 mg tissue extract and 15 mg cultured cells) were separated by SDS ± PAGE in 7.5% acrylamide minigels and electroblotted to a PVDF membrane with a TransBlot cell (BioRad Laboratories, Richmond, CA, USA) at 100 V for 70 min in 48 mM Tris, 39 mM glycine, 0.037% SDS, 20% methanol. The membrane was Coomassie-stained to check for equal transfer, then blocked and washed in TBS containing 0.1% Tween 20 and 2% low-fat milk powder, incubated for 30 min with rabbit anti-WNK1 serum Q256 (1 : 1000, Xu et al., 2000; human peptide epitope is identical), WNK1, a novel human protein kinase F Verõ Âssimo and P Jordan washed 3610 min in the same buer, incubated 30 min with the anti-rabbit antibody conjugated with horse-radish peroxidase (BioRad) and washed as above. Immunolabelled proteins were stained using a chemiluminescence reaction (ECL, Amersham).
